Patient factors associated with non-attendance at colonoscopy after a positive screening faecal occult blood test

Journal of Medical Screening

Volumn 24, Issue 1, 2017, Pages 12-19

  Plumb, Andrew A ^a   Ghanouni, Alex ^a   Rainbow, Sandra ^b   Djedovic, Natasha ^b   Marshall, Sarah ^c   Stein, Judith ^a   Taylor, Stuart A ^a   Halligan, Steve ^a   Lyratzopoulos, Georgios ^a   Von Wagner, Christian ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NORTHWICK PARK HOSPITAL   (United Kingdom)

^c ST MARK S HOSPITAL   (United Kingdom)

Author keywords

Case note review; Colonoscopy; Colorectal cancer screening; Non attendance

Indexed keywords

AGED; COLONOSCOPY; COLORECTAL TUMOR; ENGLAND; FEMALE; HUMAN; MALE; MASS SCREENING; MIDDLE AGED; NATIONAL HEALTH SERVICE; OCCULT BLOOD; PATHOLOGY; PATIENT COMPLIANCE; PROCEDURES; REMINDER SYSTEM; RETROSPECTIVE STUDY; UTILIZATION;

AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; ENGLAND; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; PATIENT COMPLIANCE; REMINDER SYSTEMS; RETROSPECTIVE STUDIES; STATE MEDICINE;

EID: 85016214970     PISSN: 09691413     EISSN: 14755793     Source Type: Journal    
DOI: 10.1177/0969141316645629     Document Type: Article

References (33)

1. Benson VS, Patnick J, Davies AK, et al. Colorectal cancer screening: a comparison of 35 initiatives in 17 countries. Int J Cancer 2008; 122: 1357–1367.
2. Schreuders EH, Ruco A, Rabeneck L, et al. Colorectal cancer screening: a global overview of existing programmes. Gut 2015; 64: 1637–1649.
3. Hewitson P, Glasziou P, Irwig L, et al. Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database Syst Rev 2007; 24: CD001216.
4. Logan RFA, Patnick J, Nickerson C, et al. Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests. Gut 2012; 61: 1439–1446.
5. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996; 348: 1472–1477.
6. Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000; 343: 1603–1607.
7. Kronborg O, Fenger C, Olsen J, et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996; 348: 1467–1471.
8. Lindholm E, Brevinge H and Haglind E. Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer. Br J Surg 2008; 95: 1029–1036.
9. Weller D, Coleman D, Robertson R, et al. The UK colorectal cancer screening pilot: results of the second round of screening in England. Br J Cancer 2007; 97: 1601–1605.
10. Leuraud K, Jezewski-Serra D, Viguier J, et al. Colorectal cancer screening by guaiac faecal occult blood test in France: evaluation of the programme two years after launching. Cancer Epidemiol 2013; 37: 959–967.
11. Correia A, Rabeneck L, Baxter NN, et al. Lack of follow-up colonoscopy after positive FOBT in an organized colorectal cancer screening program is associated with modifiable health care practices. Prev Med 2015; 76: 115–122.
12. Ferrat E, Le Breton J, Veerabudun K, et al. Colorectal cancer screening: factors associated with colonoscopy after a positive faecal occult blood test. Br J Cancer 2013; 109: 1437–1444.
13. Kearns B, Whyte S, Seaman HE, et al. Factors associated with completion of bowel cancer screening and the potential effects of simplifying the screening test algorithm. Br J Cancer 2016; 114: 327–333.
14. Partin MR, Gravely A, Gellad ZF, et al. Factors associated with missed and cancelled colonoscopy appointments at Veterans Health Administration Facilities. Clin Gastroenterol Hepatol 2016; 14: 259–267.
15. Lyratzopoulos G, Vedsted P and Singh H. Understanding missed opportunities for more timely diagnosis of cancer in symptomatic patients after presentation. Br J Cancer 2015; 112: S84–S91.
16. Carlson CM, Kirby KA, Casadei MA, et al. Lack of follow-up after fecal occult blood testing in older adults: inappropriate screening or failure to follow up? Arch Intern Med 2011; 171: 249–256.
17. Fisher DA, Jeffreys A, Coffman CJ, et al. Barriers to full colon evaluation for a positive fecal occult blood test. Cancer Epidemiol Biomarkers Prev 2006; 15: 1232–1235.
18. Jimbo M, Myers RE, Meyer B, et al. Reasons patients with a positive fecal occult blood test result do not undergo complete diagnostic evaluation. Ann Fam Med 2009; 7: 11–16.
19. Braun V and Clarke V. Using thematic analysis in psychology. Qual Res Psychol 2006; 3: 77–101.
20. Ritchie J, Spencer L and O’Connor W. Carrying out qualitative analysis. In: Ritchie J and Lewis J, eds Qualitative research practice. London: SAGE Publications, 2003:219–262.
21. McLachlan S-A, Clements A and Austoker J. Patients’ experiences and reported barriers to colonoscopy in the screening context— a systematic review of the literature. Patient Educ Counsel 2011; 86: 137–146.
22. Felsen CB, Piasecki A, Ferrante JM, et al. Colorectal cancer screening among primary care patients: does risk affect screening behavior? J Community Health 2011; 36: 605–611.
23. Kiviniemi MT, Bennett A, Zaiter M, et al. Individual-level factors in colorectal cancer screening: a review of the literature on the relation of individual-level health behavior constructs and screening behavior. Psycho-oncology 2011; 20: 1023–1033.
24. Shields HM, Weiner MS, Henry DR, et al. Factors that influence the decision to do an adequate evaluation of a patient with a positive stool for occult blood. Am J Gastroenterol 2001; 96: 196–203.
25. Zheng Y-F, Saito T, Takahashi M, et al. Factors associated with intentions to adhere to colorectal cancer screening follow-up exams. BMC Public Health 2006; 6: 272.
26. Banks J, Hollinghurst S, Bigwood L, et al. Preferences for cancer investigation: a vignette-based study of primary-care attendees. Lancet Oncol 2014; 15: 232–240.
27. de Wijkerslooth TR, de Haan MC, Stoop EM, et al. Reasons for participation and nonparticipation in colorectal cancer screening: a randomized trial of colonoscopy and CT colonography. Am J Gastroenterol 2012; 107: 1777–1783.
28. Ho W, Broughton DE, Donelan K, et al. Analysis of barriers to and patients’ preferences for CT colonography for colorectal cancer screening in a nonad-herent urban population. Am J Roentgenol 2010; 195: 393–397.
29. Sali L, Grazzini G, Ventura L, et al. Computed tomographic colonography in subjects with positive faecal occult blood test refusing optical colonoscopy. Dig Liver Dis 2013; 45: 285–289.
30. Denberg TD, Melhado TV, Coombes JM, et al. Predictors of nonadherence to screening colonoscopy. J Gen Intern Med 2005; 20: 989–995.
31. Hewitson P, Ward AM, Heneghan C, et al. Primary care endorsement letter and a patient leaflet to improve participation in colorectal cancer screening: results of a factorial randomised trial. Br J Cancer 2011; 105: 475–480.
32. Paskett ED, Harrop JP and Wells KJ. Patient navigation: an update on the state of the science. CA Cancer J Clin 2011; 61: 237–249.
33. Green BB, Anderson ML, Wang CY, et al. Results of nurse navigator follow-up after positive colorectal cancer screening test: a randomized trial. JAm Board Fam Med 2014; 27: 789–795.